Intel's stock is experiencing a significant decline of 6.18% today, driven by reports of potential delays and cost overruns in its chip fabrication expansion plans. These concerns have raised alarms about the company's ability to ramp up production on schedule and within budget, particularly in its U.S. manufacturing facilities. Investors are worried that extended timelines and increased costs could hinder Intel's competitive position in the semiconductor market and delay anticipated revenue and margin improvements from its manufacturing turnaround efforts.
